Planning for uncertainty with simulation and optimization
How companies can move beyond point forecasts by combining scenarios, predictive models and optimization to improve decisions under volatile conditions.
Read articleRelated macro
Pharmaceuticals, biotechnology and life sciences
Turn scientific innovation into durable portfolio value as patent exposure, access pressure and R&D economics reshape life sciences.
Discover the macroEditorial overview
Articles
Digital transformation after the transformation era
Why the next digital agenda is less about isolated programs and more about architecture, platforms, governance and measurable enterprise value.
Read articleFocus
Fintech is moving from digitizing finance toward redesigning financial infrastructure
Stablecoins, tokenization and embedded finance are increasingly testing where banks, technology firms and payment networks should sit.
Industrial distribution is being squeezed between inventory risk and customer expectations
Tariffs, supplier volatility and digital purchasing are forcing distributors to rethink stock, service and the value they add between manufacturer and buyer.
Strategic challenges
Can telcos become technology companies without losing focus on connectivity?
The challenge is finding adjacent businesses with enough margin and differentiation to justify moving beyond the network core.
Which property sectors deserve capital when performance diverges this sharply?
The challenge is comparing traditional assets with data centers, living, healthcare and other operational sectors under different demand and risk conditions.
POV
AI will not fix biopharma economics by improving discovery alone
The larger productivity problem spans development, evidence, regulatory execution and the capital consumed before a medicine reaches patients.
The platform that owns the transaction may no longer own the customer journey
AI agents could separate discovery from execution, challenging one of the basic assumptions behind marketplace power.
Strategic impact
New care models can shift scarce clinical capacity toward higher-value work
Virtual care, automation and redesigned pathways can change where patients are treated and which tasks require specialist intervention.
A more selective traveler is making experience quality economically visible
Operators with differentiated service and stronger loyalty can better defend spend when customers begin questioning discretionary trips.
What we observe
Travel companies often mistake post-pandemic pricing power for permanent demand strength
Exceptional willingness to spend can normalize, exposing propositions that relied more on scarcity and pent-up demand than differentiation.
Private-capital portfolios often look diversified while underlying exposures converge
Shared borrowers, similar financing structures and overlapping strategies can create more correlation than fund-level labels suggest.